Oncology & Cancer
Lung cancer: Predicting which patients are at high risk of recurrence to improve outcomes
Lung cancer is responsible for more deaths than breast, colon and prostate cancer combined.
Feb 19, 2024
0
0
News tagged with prostate tumour
Oncology & Cancer
Cancer-causing mutations rewire growth signaling in prostate cancer model
Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators. This discovery has implications for potential therapeutics ...
Sep 11, 2023
0
21
Oncology & Cancer
Prostate cancer: "Liquid biopsies" allow non-invasive diagnosis of metastatic cancers
In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis of patients with advanced prostate cancer. A research team from the Medical University of Vienna and the Ludwig ...
Jan 21, 2022
0
52
Oncology & Cancer
Improving care for people with rare neuroendocrine tumors
A revolutionary new way of caring for people with neuroendocrine tumors (NETs) will be trialed in the coming months, with the Flinders University-led project aiming to improve patient quality of life and develop a cost-effective ...
Jan 10, 2022
0
2
Oncology & Cancer
Tissue-engineered prostate tumours shed light on cancer spread
The international team led by Dr. Jacqui McGovern, from the Centre for Biomedical Technologies, used tissue engineering and regenerative medicine principles to create primary tumors with their microenvironment and humanized ...
Sep 28, 2021
0
46
Medical research
Understanding and targeting prostate cancer metabolism
South Australian medical researchers have identified a new way in which prostate cancer cells use glucose to grow and survive, which in turn could be the secret to destroying them.
Aug 27, 2021
0
161
Medications
New BRCA-targeting drug could offer hope in treating advanced prostate cancer
Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate cancer who have run out of options, a phase II clinical trial shows.
Aug 23, 2021
0
129
Oncology & Cancer
Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer
Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer at stages where the disease has spread to the bones.
Jul 7, 2021
0
20
Medical research
Research uncovers additional treatment option in prostate cancer
The standard treatment for advanced metastatic prostate cancer (PCa) is androgen deprivation therapy (ADT). And even if this is efficient in the short term, 1/3 of PCa will become resistant to ADT and develop castration-resistant ...
Mar 29, 2021
0
88
Oncology & Cancer
Prostate cancer: ยต-crystallin (CRYM) protein inhibits tumour growth
Prostate cancer is caused by elevated hormone levels, and tumors are generally treated using hormone therapy. However, after some time, tumor growth is no longer dependent on hormones, which results in resistance to treatment. ...
Nov 18, 2020
0
7
